(Q38300930)

1 September 2017

title

Pharmacological characterization of the dermorphin analog [Dmt(1)]DALDA, a highly potent and selective mu-opioid peptide (English)

1 reference

1 September 2017

C L Neilan

1

1 reference

1 September 2017

T M Nguyen

series ordinal

2

1 reference

1 September 2017

P W Schiller

series ordinal

3

1 reference

1 September 2017

G W Pasternak

series ordinal

4

1 reference

1 September 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

European Journal of Pharmacology

1 September 2017

published in

1 reference

1 September 2017

volume

419

1 reference

1 September 2017

issue

1

1 reference

1 September 2017

page(s)

15-23

1 reference

Opiate receptors in mice: Genetic differences

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900946-3

3-Methoxynaltrexone, a selective heroin/morphine-6beta-glucuronide antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900946-3

Enhanced antinociception of the model opioid peptide [D-penicillamine] enkephalin by P-glycoprotein modulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900946-3

Etonitazene-induced antinociception in mu1 opioid receptor deficient CXBK mice: evidence for a role for mu2 receptors in supraspinal antinociception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900946-3

Systemic analgesic activity and delta-opioid selectivity in [2,6-dimethyl-Tyr1,D-Pen2,D-Pen5]enkephalin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900946-3

Cardiovascular effects of a mu-selective opioid agonist (tyrosine-D-arginine-phenylalanine-lysine-NH2) in fetal sheep: sites and mechanisms of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900946-3

Role of blood-brain barrier P-glycoprotein in limiting brain accumulation and sedative side-effects of asimadoline, a peripherally acting analgaesic drug

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900946-3

P-glycoprotein-mediated transport of morphine in brain capillary endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900946-3

Dissociation of morphine's analgesic and respiratory depressant actions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900946-3

Naloxonazine actions in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900946-3

mu Opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900946-3

Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900946-3

Production of antinociception by peripheral administration of [Lys7]dermorphin, a naturally occurring peptide with high affinity for mu-opioid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900946-3

Identification and characterization of three new alternatively spliced mu-opioid receptor isoforms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900946-3

Isolation and expression of a novel alternatively spliced mu opioid receptor isoform, MOR-1F.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900946-3

Incomplete cross tolerance and multiple mu opioid peptide receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900946-3

Mapping of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900946-3

Different mu receptor subtypes mediate spinal and supraspinal analgesia in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900946-3

(D-Ala2)-Met-enkephalinamide: a potent, long-lasting synthetic pentapeptide analgesic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900946-3

Strain differences in opiate receptors in mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900946-3

Blockade of morphine analgesia by an antisense oligodeoxynucleotide against the mu receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900946-3

Antisense mapping the MOR-1 opioid receptor: evidence for alternative splicing and a novel morphine-6 beta-glucuronide receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900946-3

Differential blockade of morphine and morphine-6 beta-glucuronide analgesia by antisense oligodeoxynucleotides directed against MOR-1 and G-protein alpha subunits in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900946-3

Novel receptor mechanisms for heroin and morphine-6 beta-glucuronide analgesia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900946-3

Dermorphin analogues carrying an increased positive net charge in their "message" domain display extremely high mu opioid receptor selectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900946-3

Synthesis and in vitro opioid activity profiles of DALDA analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900946-3

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900946-3

Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900946-3

Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900946-3

Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900946-3

G proteins and opioid receptor-mediated signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900946-3

Opiate-induced analgesia is increased and prolonged in mice lacking P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900946-3

10.1016/S0014-2999(01)00946-3

7 January 2021

Identifiers

DOI

1 reference

1 September 2017

1 reference